Literature DB >> 2871859

Measurement of high molecular weight forms of enzymes in serum in the detection of hepatic metastases of colorectal cancer.

O J Traynor, C B Wood, Z O Echetebu, K B Whitaker, D W Moss.   

Abstract

Total gamma-glutamyl transferase and alkaline phosphatase, liver-specific alkaline phosphatase and high molecular weight forms of the two enzymes were measured in the sera of 42 patients with colorectal cancer, of whom 26 were apparently metastases-free and 16 had palpable liver metastases. The average levels of all enzymes were significantly higher in the group with metastases, but there was considerable overlap between the groups. The predictive values of positive results were of the order of 50-75%; predictive values of negative results were more than 70% for all tests, with high molecular weight alkaline phosphatase (87%) performing best in this respect. However, measurement of high molecular weight enzymes does not offer marked advantages over more conventional enzyme tests in the detection of hepatic metastases of colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2871859      PMCID: PMC2001446          DOI: 10.1038/bjc.1986.76

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  26 in total

1.  A simplified heat-inactivation method for investigating alkaline phosphatase isoenzymes in serum.

Authors:  D W Moss; L G Whitby
Journal:  Clin Chim Acta       Date:  1975-05-15       Impact factor: 3.786

2.  Tumors of the liver as demonstrated by angiography, scan and laparotomy.

Authors:  D K Kim; J McSweeney; S D Yeh; J G Fortner
Journal:  Surg Gynecol Obstet       Date:  1975-09

Review 3.  Gamma-glutamyl transpeptidase.

Authors:  S B Rosalki
Journal:  Adv Clin Chem       Date:  1975       Impact factor: 5.394

4.  Activities of bone and liver alkaline phosphatases in serum in health and disease.

Authors:  K B Whitaker; L G Whitby; D W Moss
Journal:  Clin Chim Acta       Date:  1977-10-01       Impact factor: 3.786

5.  The reliability of liver scans and function tests in detecting metastases.

Authors:  J Castagna; J R Benfield; H Yamada; D E Johnson
Journal:  Surg Gynecol Obstet       Date:  1972-03

6.  Liver function tests in metastatic tumor of the liver: study of 100 cases.

Authors:  J Schaefer; L Schiff
Journal:  Gastroenterology       Date:  1965-10       Impact factor: 22.682

7.  The separation and characterization of liver plasma membrane fragments circulating in the blood of patients with cholestasis.

Authors:  M E De Broe; M Borgers; R J Wieme
Journal:  Clin Chim Acta       Date:  1975-03-24       Impact factor: 3.786

8.  Multivariate analysis of a personal series of 247 patients with liver metastases from colorectal cancer. II. Treatment by intrahepatic chemotherapy.

Authors:  J G Fortner; J S Silva; E B Cox; R B Golbey; H Gallowitz; B J Maclean
Journal:  Ann Surg       Date:  1984-03       Impact factor: 12.969

9.  The preoperative diagnosis of hepatic metastases in cases of colorectal carcinoma.

Authors:  D R Read; E Hambrick; H Abcarian; H Levine
Journal:  Dis Colon Rectum       Date:  1977-03       Impact factor: 4.585

10.  The contribution of serum enzymes and carcinoembryonic antigen to the early diagnosis of metastatic colorectal cancer.

Authors:  E H Cooper; R Turner; L Steele; A M Neville; A M Mackay
Journal:  Br J Cancer       Date:  1975-01       Impact factor: 7.640

View more
  1 in total

1.  Factors affecting the ability of glycosylphosphatidylinositol-specific phospholipase D to degrade the membrane anchors of cell surface proteins.

Authors:  M G Low; K S Huang
Journal:  Biochem J       Date:  1991-10-15       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.